{"name":"Neal D. Bhatia, MD","slug":"neal-d-bhatia-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ingenol mebutate 0.05% gel","genericName":"ingenol mebutate 0.05% gel","slug":"ingenol-mebutate-0-05-gel","indication":"Actinic keratosis (field treatment on face or scalp)","status":"marketed"}]}],"pipeline":[{"name":"ingenol mebutate 0.05% gel","genericName":"ingenol mebutate 0.05% gel","slug":"ingenol-mebutate-0-05-gel","phase":"marketed","mechanism":"Ingenol mebutate activates protein kinase C (PKC) to induce rapid necrosis of actinic keratosis cells and promote immune-mediated clearance of damaged skin.","indications":["Actinic keratosis (field treatment on face or scalp)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOalN6OVdBS3QzYlJrVnd0eGNYOE8xcFZ4WGx1ZmM1VVlQemdWVlhFQ0tQWDNsR3NkcE5ENG5UdDNSalZLblJKaEJLaGpWUXR6QmM3WXdYdUhYb3czUE9ZM3dRSmtLbnlWMnBQaTNpbUlyQ09SUXFlUVNNLUpXRkRBNVcxdXRKaEtPaDgzbkM2bHdSb2xFMk9FOG1MeXFyRW1SbmdGM2l5Ym5wRzQ?oc=5","date":"2026-03-02","type":"pipeline","source":"HCPLive","summary":"Discussing GLP-1 or Dual Incretin Therapies in IL-17 Mediated Disease, With Neal Bhatia, MD - HCPLive","headline":"Discussing GLP-1 or Dual Incretin Therapies in IL-17 Mediated Disease, With Neal Bhatia, MD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxORW8yOWozeVBpNHZfZlAyX3NWVjFuakZxWURTX3NTZTViMlF4Y0tXakIxN2NiTmg3aVBwUWdTUC1LVDhGS0RqRWlZNS13YzJBSFhQUEhRdVRWWW53S0wzVFpFd2UyTUtQRlYydVFoMlRsRDRXbDFHT2dyVFppVmgwMlBSaHhVNkkzcl9oRUtLaEViQklnN0pB?oc=5","date":"2026-01-27","type":"pipeline","source":"HCPLive","summary":"Discussing GLP-1s, New Dermatology Therapies in 2026, With Neal Bhatia, MD - HCPLive","headline":"Discussing GLP-1s, New Dermatology Therapies in 2026, With Neal Bhatia, MD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPZlByS3Nqanc0MTdHbjNKWTctVENqR3ExY2ZHR0VGMHZtN2FSU0hsSGp2SXh3eWxNV0pMMTR0NjhnSVRlM3lSRFB0WWhlRFBYVHFjWFdoRk52TWxjLWE1OFVHSDJ4VGQ4QS1adkphcXljaHh5NzJzdzRYM0tUZDhqMDYzVFgtVV8wUnJBZllSc1FtNkl3ZzRzRkdFejJTcWktOUdIVWJyOTJhQQ?oc=5","date":"2025-09-25","type":"pipeline","source":"HCPLive","summary":"Discussing Tirbanibulin, Unmet Needs of Patients with Actinic Keratosis, With Neal Bhatia, MD - HCPLive","headline":"Discussing Tirbanibulin, Unmet Needs of Patients with Actinic Keratosis, With Neal Bhatia, MD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNNU1BX0ViRWJkLWI1NVUtS1FsSkRYaWxCWVZPWXlCNzYxVk5jVHdENVRHLWo0aGZiRDZaSWU3dm1FQ3dYWHFXYzE1al9nSFNzY0tsbmNCYnFWTWtXanJDNmNma28wQjJDYmZTY2xMOEJUYktNSWJzVGNPMm5HaUs5eTljdC1NaGdnUEpYWndNeGNWZ0hLbUI5cklhSXJhWlViU1g2aTQ3ZkdRZXI5?oc=5","date":"2025-09-24","type":"trial","source":"HCPLive","summary":"Spotlighting Data on Clearance of Actinic Keratosis Using Tirbanibulin, With Neal Bhatia, MD - HCPLive","headline":"Spotlighting Data on Clearance of Actinic Keratosis Using Tirbanibulin, With Neal Bhatia, MD","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}